累积吸烟剂量与非慢性肾脏病个体亚临床肾损伤相关:一项病理学研究
研究分析547例活体肾移植供者零点活检标本,评估吸烟与肾脏组织学改变的关系。199例(36.4%)有吸烟史,其中92例(16.8%)累积<20包年、107例(19.6%)≥20包年。累积吸烟剂量与细动脉透明变性患病率显著相关,每增加20包年多变量校正OR为1.50(95%CI 1.15-1.97);与从不吸烟者相比,<20包年者和≥20包年者OR分别为1.76(1.01-3.09)和2.56(1.48-4.44)。吸烟亦与>10%全球肾小球硬化患病率相关,每增加20包年OR为1.24(0.96-1.59);<20包年者和≥20包年者OR分别为1.50(0.98-2.78)和2.11(1.18-3.79)。小-中型动脉内膜增厚及IF/TA与吸烟状态无关。戒烟≥10年者细动脉透明变性患病率仍高于从不吸烟者[OR 2.23(1.03-4.83)]。结论认为吸烟所致亚临床病理损伤可能与肾细动脉透明变性和肾小球缺血有关。
要点
- 547例活体肾移植供者零点活检中36.4%有吸烟史,≥20包年者占19.6%。
- 每增加20包年,细动脉透明变性多变量校正OR为1.50(95%CI 1.15-1.97)。
- 戒烟≥10年者细动脉透明变性患病率仍高于从不吸烟者[OR 2.23(1.03-4.83)]。
核心结论
- 吸烟所致亚临床病理损伤可能与肾细动脉透明变性和肾小球缺血有关。
研究设计与样本
- 研究纳入547例活体肾移植供者的零点活检标本,分析吸烟与肾脏组织学改变的关系。
主要发现
- 547例中199例(36.4%)有吸烟史,92例(16.8%)累积<20包年,107例(19.6%)累积≥20包年。
- 累积吸烟剂量与细动脉透明变性患病率显著相关,每增加20包年多变量校正OR为1.50(95%CI 1.15-1.97)。
- 与从不吸烟者相比,<20包年者和≥20包年者细动脉透明变性OR分别为1.76(95%CI 1.01-3.09)和2.56(95%CI 1.48-4.44)。
- 吸烟与>10%全球肾小球硬化患病率相关,每增加20包年OR为1.24(95%CI 0.96-1.59);<20包年者和≥20包年者OR分别为1.50(95%CI 0.98-2.78)和2.11(95%CI 1.18-3.79)。
- 小-中型动脉内膜增厚及IF/TA与吸烟状态无关;戒烟≥10年者细动脉透明变性患病率仍高于从不吸烟者[OR 2.23(95%CI 1.03-4.83)]。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Epidemiological studies have identified smoking as an independent risk factor for development of chronic kidney disease. However, the early renal pathological lesions have not been clearly elucidated. METHODS: We investigated time-zero biopsy specimens from 547 living kidney donors and evaluated the relationships between smoking and renal histological changes, including arteriolar hyalinization, intimal thickening of small-medium arteries, global glomerulosclerosis, and interstitial fibrosis and tubular atrophy (IF/TA). RESULTS: A total of 199 subjects (36.4%) had smoking history; 92 (16.8%) and 107 (19.6%) subjects had <20 pack-years and ≥20 pack-years of smoking, respectively. Cumulative smoking dose was significantly associated with prevalence of arteriolar hyalinization: the multivariable-adjusted odds ratio (OR) per 20 pack-year increase was 1.50 (95% confidence interval 1.15-1.97). The ORs for smokers with <20 pack-years and ≥20 pack-years versus never-smokers were 1.76 (1.01-3.09) and 2.56 (1.48-4.44), respectively. Smoking was also associated with prevalence of >10% global glomerulosclerosis: the OR per 20 pack-year increase was 1.24 (0.96-1.59). The ORs for smokers with <20 pack-years and ≥20 pack-years versus never-smokers were 1.50 (0.98-2.78) and 2.11 (1.18-3.79), respectively. The ORs for these pathological changes increased significantly depending on cumulative smoking dose. Intimal thickening of small-medium arteries and IF/TA were not associated with smoking status. The prevalence of arteriolar hyalinization remained higher in patients with ≥10 years since smoking cessation than in never-smokers [OR 2.23 (1.03-4.83)]. CONCLUSIONS: Subclinical pathological injury caused by smoking is potentially associated with renal arteriolar hyalinization and glomerular ischaemia.
引用
- Ataka E, Matsukuma Y, Ueki K, et al. Cumulative smoking dose is associated with subclinical renal injury: a pathological study in individuals without chronic kidney disease. Nephrol Dial Transplant. 2023. PMID: 37355777. doi:10.1093/ndt/gfad124
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。